IBDEI29E ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37945,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,37945,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,37945,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,37946,0)
 ;;=F32.9^^175^1907^10
 ;;^UTILITY(U,$J,358.3,37946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37946,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,37946,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,37946,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,37947,0)
 ;;=G54.6^^175^1907^12
 ;;^UTILITY(U,$J,358.3,37947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37947,1,3,0)
 ;;=3^Phantom Limb Syndrome w/ Pain
 ;;^UTILITY(U,$J,358.3,37947,1,4,0)
 ;;=4^G54.6
 ;;^UTILITY(U,$J,358.3,37947,2)
 ;;=^5004013
 ;;^UTILITY(U,$J,358.3,37948,0)
 ;;=G54.7^^175^1907^13
 ;;^UTILITY(U,$J,358.3,37948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37948,1,3,0)
 ;;=3^Phantom Limb Syndrome w/o Pain
 ;;^UTILITY(U,$J,358.3,37948,1,4,0)
 ;;=4^G54.7
 ;;^UTILITY(U,$J,358.3,37948,2)
 ;;=^5004014
 ;;^UTILITY(U,$J,358.3,37949,0)
 ;;=M62.40^^175^1907^11
 ;;^UTILITY(U,$J,358.3,37949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37949,1,3,0)
 ;;=3^Muscle Contracture,Unspec Site
 ;;^UTILITY(U,$J,358.3,37949,1,4,0)
 ;;=4^M62.40
 ;;^UTILITY(U,$J,358.3,37949,2)
 ;;=^5012631
 ;;^UTILITY(U,$J,358.3,37950,0)
 ;;=R68.89^^175^1907^8
 ;;^UTILITY(U,$J,358.3,37950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37950,1,3,0)
 ;;=3^General Signs & Symptoms,Other
 ;;^UTILITY(U,$J,358.3,37950,1,4,0)
 ;;=4^R68.89
 ;;^UTILITY(U,$J,358.3,37950,2)
 ;;=^5019557
 ;;^UTILITY(U,$J,358.3,37951,0)
 ;;=R39.89^^175^1907^9
 ;;^UTILITY(U,$J,358.3,37951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37951,1,3,0)
 ;;=3^Genitourinary System Signs & Symptoms,Other
 ;;^UTILITY(U,$J,358.3,37951,1,4,0)
 ;;=4^R39.89
 ;;^UTILITY(U,$J,358.3,37951,2)
 ;;=^5019350
 ;;^UTILITY(U,$J,358.3,37952,0)
 ;;=B02.23^^175^1908^1
 ;;^UTILITY(U,$J,358.3,37952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37952,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,37952,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,37952,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,37953,0)
 ;;=B02.22^^175^1908^2
 ;;^UTILITY(U,$J,358.3,37953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37953,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,37953,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,37953,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,37954,0)
 ;;=C15.9^^175^1909^8
 ;;^UTILITY(U,$J,358.3,37954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37954,1,3,0)
 ;;=3^Malig Neop Esophagus,Unspec
 ;;^UTILITY(U,$J,358.3,37954,1,4,0)
 ;;=4^C15.9
 ;;^UTILITY(U,$J,358.3,37954,2)
 ;;=^5000919
 ;;^UTILITY(U,$J,358.3,37955,0)
 ;;=C22.8^^175^1909^13
 ;;^UTILITY(U,$J,358.3,37955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37955,1,3,0)
 ;;=3^Malig Neop Liver,Primary,Unspec Type
 ;;^UTILITY(U,$J,358.3,37955,1,4,0)
 ;;=4^C22.8
 ;;^UTILITY(U,$J,358.3,37955,2)
 ;;=^5000939
 ;;^UTILITY(U,$J,358.3,37956,0)
 ;;=C22.0^^175^1909^5
 ;;^UTILITY(U,$J,358.3,37956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37956,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,37956,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,37956,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,37957,0)
 ;;=C22.2^^175^1909^1
 ;;^UTILITY(U,$J,358.3,37957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37957,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,37957,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,37957,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,37958,0)
 ;;=C22.7^^175^1909^4
 ;;^UTILITY(U,$J,358.3,37958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37958,1,3,0)
 ;;=3^Liver Carcinomas,Oth Spec
